BG60249B2 - Thiazole compound for treatment of ulcers - Google Patents

Thiazole compound for treatment of ulcers

Info

Publication number
BG60249B2
BG60249B2 BG53730A BG5373081A BG60249B2 BG 60249 B2 BG60249 B2 BG 60249B2 BG 53730 A BG53730 A BG 53730A BG 5373081 A BG5373081 A BG 5373081A BG 60249 B2 BG60249 B2 BG 60249B2
Authority
BG
Bulgaria
Prior art keywords
ulcers
treatment
thiazole compound
compound
thiazole
Prior art date
Application number
BG53730A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG60249B1 (bg
Inventor
Richard Pioch
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22712591&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG60249(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of BG60249B1 publication Critical patent/BG60249B1/bg
Publication of BG60249B2 publication Critical patent/BG60249B2/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28Radicals substituted by nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BG53730A 1980-10-02 1981-10-02 Thiazole compound for treatment of ulcers BG60249B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/193,192 US4375547A (en) 1980-10-02 1980-10-02 N-Methyl-N'-2-([(2-dimethylaminomethyl)-4-thiazolyl]methylthio)ethyl 2-nitro-1,1-ethenediamine

Publications (2)

Publication Number Publication Date
BG60249B1 BG60249B1 (bg) 1994-03-24
BG60249B2 true BG60249B2 (en) 1994-03-24

Family

ID=22712591

Family Applications (1)

Application Number Title Priority Date Filing Date
BG53730A BG60249B2 (en) 1980-10-02 1981-10-02 Thiazole compound for treatment of ulcers

Country Status (36)

Country Link
US (1) US4375547A (en:Method)
EP (1) EP0049618B1 (en:Method)
JP (1) JPS5791980A (en:Method)
KR (1) KR850001795B1 (en:Method)
AR (1) AR241439A1 (en:Method)
AU (1) AU542553B2 (en:Method)
BG (1) BG60249B2 (en:Method)
CA (1) CA1166248A (en:Method)
CS (1) CS227015B2 (en:Method)
CY (1) CY1351A (en:Method)
DD (1) DD200371A5 (en:Method)
DE (1) DE3171819D1 (en:Method)
DK (2) DK164056C (en:Method)
EG (1) EG15678A (en:Method)
ES (2) ES8301950A1 (en:Method)
FI (2) FI813058L (en:Method)
GB (1) GB2084581B (en:Method)
GR (1) GR75023B (en:Method)
HK (1) HK15987A (en:Method)
HU (1) HU188697B (en:Method)
IE (1) IE51603B1 (en:Method)
IL (1) IL63980A (en:Method)
LU (1) LU88293I2 (en:Method)
MX (1) MX5723A (en:Method)
MY (1) MY8700247A (en:Method)
NL (1) NL930107I2 (en:Method)
NO (1) NO155885C (en:Method)
NZ (1) NZ198523A (en:Method)
PH (1) PH18135A (en:Method)
PL (2) PL130626B1 (en:Method)
PT (1) PT73757B (en:Method)
RO (2) RO85815B (en:Method)
SU (1) SU1184443A3 (en:Method)
UA (1) UA6081A1 (en:Method)
YU (1) YU42728B (en:Method)
ZA (1) ZA816817B (en:Method)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4904792A (en) * 1980-10-02 1990-02-27 Eli Lilly And Company N-thiazolymethylthioalkyl-N'-alkylamidines and related compounds
CA1206151A (en) * 1981-12-28 1986-06-17 Richard P. Pioch Pyrimidone anti-ulcer agents
US4474794A (en) * 1982-03-19 1984-10-02 Eli Lilly And Company N-Thiazolylmethylthioalkyl-N1 -alkenyl (or alkynyl)guanidines and related compounds
FR2531703A1 (fr) * 1982-08-13 1984-02-17 Sanofi Sa 2-aza-5-thiahexan-1-ones 1,6-disubstituees, leurs sels, procede pour leur preparation et compositions pharmaceutiques les renfermant
US4587344A (en) * 1983-02-07 1986-05-06 Eli Lilly And Company Isothiourea synthesis process
PT78063A (en) * 1983-02-07 1984-03-01 Lilly Co Eli Improvements in or relating to the process of synthesis of nizatidine
US4468517A (en) * 1983-05-12 1984-08-28 Eli Lilly And Company Synthesis of thiazoles
DE3417127A1 (de) * 1984-05-09 1985-11-14 Papst-Motoren GmbH & Co KG, 7742 St Georgen Kleinstventilator
DE3531504A1 (de) * 1985-09-04 1987-03-12 Basf Ag 3-aminomethylpyrrol-1-yl-alkylamine und diese verbindungen enthaltende therapeutische mittel
US4777260A (en) * 1985-12-18 1988-10-11 Eli Lilly And Company Synthesis of nizatidine intermediate
IL80961A0 (en) * 1985-12-18 1987-03-31 Lilly Co Eli Synthesis of nizatidine
ATE86619T1 (de) * 1987-04-06 1993-03-15 Heumann Pharma Gmbh & Co Verfahren zur herstellung von nitroethenderivaten.
ES2007959A6 (es) * 1988-07-11 1989-07-01 Vinas Lab Procedimiento para la obtencion de derivados tiazolicos.
DK0515121T3 (da) * 1991-05-21 2000-11-27 Lilly Co Eli Fremgangsmåde til fremstilling af mellemprodukter for nizatidin og beslægtede forbindelser
ES2038922B1 (es) * 1991-12-30 1994-04-16 Fermentaciones Y Sintesis Espa Procedimiento para la obtencion de nizatidina.
US5294433A (en) * 1992-04-15 1994-03-15 The Procter & Gamble Company Use of H-2 antagonists for treatment of gingivitis
AU662454B2 (en) * 1992-05-12 1995-08-31 Zeria Pharmaceutical Co., Ltd. Novel quaternary ammonium salts and use thereof as medicine
US5541335A (en) * 1994-07-11 1996-07-30 Torcan Chemical Ltd. Process for preparing nizatidine
US5470865A (en) * 1994-08-30 1995-11-28 Eli Lilly And Company Pharmaceutical composition
JP2001500499A (ja) * 1996-09-11 2001-01-16 クノル アクチエンゲゼルシャフト ニザチジンの製造方法
IT1299198B1 (it) 1998-03-05 2000-02-29 Nicox Sa Sali nitrati di farmaci antiulcera
JP2002529503A (ja) 1998-11-17 2002-09-10 ニトロメッド,インク. ニトロソ化及びニトロシル化h2リセプターアンタゴニスト化合物及び組成物並びにその利用方法
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
EP1750674A4 (en) * 2004-05-27 2012-05-23 Advanced Bionutrition Corp MICROPARTICLES FOR THE ORAL LEVY
US20080045575A1 (en) * 2004-12-29 2008-02-21 Van Dyke Thomas E Delivery of H2 Antagonists
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
US20090275622A1 (en) * 2008-04-30 2009-11-05 Prasoona Linga Nizatidine formulations
WO2013135852A1 (en) 2012-03-15 2013-09-19 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
HUE054186T2 (hu) 2013-07-19 2021-08-30 Boehringer Ingelheim Vetmedica Gmbh Éterezett ciklodextrin-származékokat tartalmazó, tartósított, folyékony, vizes gyógyászati készítmény
WO2015082389A1 (en) 2013-12-04 2015-06-11 Boehringer Ingelheim Vetmedica Gmbh Improved pharmaceutical compositions of pimobendan
EP2929884A1 (en) 2014-04-11 2015-10-14 Sanovel Ilac Sanayi ve Ticaret A.S. Pharmaceutical combinations of dabigatran and h2-receptor antagonists
WO2015169957A1 (en) 2014-05-09 2015-11-12 Sanovel Ilac Sanayi Ve Ticaret A.S. Pharmaceutical combinations of rivaroxaban and h2-receptor antagonists
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
US3917593A (en) * 1972-05-22 1975-11-04 Smithkline Corp N-alkenyl and N-alkynyl (2-quinolyl)thio-acetamides
US3853865A (en) * 1972-06-26 1974-12-10 Smithkline Corp N-aminomethyl-2-amino(and 2-amino-methyl)-2-heterocyclic-thioacetamides
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
US4191769A (en) * 1974-03-12 1980-03-04 Smith Kline & French Laboratories Limited Isothiourea compounds and pharmacological use
US4061637A (en) * 1974-05-14 1977-12-06 Istituto Luso Farmaco D'italia S.R.L. Certain 4-aryl-5-(4-phenylpiperazino)alkyl-4-thiazolin-2-ones
US4173644A (en) * 1975-02-03 1979-11-06 Smith Kline & French Laboratories Limited Thiourea compounds, compositions and methods and use
US4166856A (en) * 1975-05-21 1979-09-04 Smith Kline & French Laboratories Limited Thiazole and isothiazole derivative as blockers of histamine H2 -receptors
GB1574214A (en) * 1976-03-11 1980-09-03 Smith Kline French Lab Amidines
GB1602458A (en) * 1977-05-05 1981-11-11 Smith Kline French Lab Bisamidines as histamine h2-antagonists
DE2835695A1 (de) * 1977-08-29 1979-03-15 Yamanouchi Pharma Co Ltd Neue heterocyclische verbindungen, verfahren zu ihrer herstellung und arzneimittel, die diese enthalten
JPS5444660A (en) * 1977-08-29 1979-04-09 Yamanouchi Pharmaceut Co Ltd Heterocyclic compound and its preparation
US4210658A (en) * 1977-09-08 1980-07-01 Smith Kline & French Laboratories Limited Amidinosulphonic acid derivatives
DE2905134A1 (de) * 1978-02-17 1979-08-23 Degussa Neue acylierte aminoalkyl-cyanoguanidine mit einem heterocyclischen rest
ATE1353T1 (de) * 1978-05-24 1982-08-15 Imperial Chemical Industries Plc Anti-sekretion thiadiazol-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
US4200578A (en) * 1978-12-18 1980-04-29 Bristol-Myers Company Thiazole derivatives

Also Published As

Publication number Publication date
JPS5791980A (en) 1982-06-08
CS227015B2 (en) 1984-04-16
CY1351A (en) 1987-04-24
ES8306135A1 (es) 1983-05-01
HK15987A (en) 1987-02-27
YU42728B (en) 1988-12-31
RO85815A (ro) 1984-11-25
HU188697B (en) 1986-05-28
US4375547A (en) 1983-03-01
DE3171819D1 (en) 1985-09-19
NO813334L (no) 1982-04-05
NL930107I1 (nl) 1993-10-18
LU88293I2 (fr) 1994-05-04
UA6081A1 (uk) 1994-12-29
DK12391A (da) 1991-01-24
RO85815B (ro) 1984-11-30
DK164056B (da) 1992-05-04
DK167759B1 (da) 1993-12-13
PL130626B1 (en) 1984-08-31
PT73757A (en) 1981-11-01
FI813058L (fi) 1982-04-03
KR850001795B1 (ko) 1985-12-21
AU7594581A (en) 1982-04-08
MX5723A (es) 1993-12-01
RO82215A (ro) 1983-07-07
NL930107I2 (nl) 1997-02-03
ES514868A0 (es) 1983-05-01
PH18135A (en) 1985-04-03
RO82215B (ro) 1983-06-30
GB2084581A (en) 1982-04-15
BG60249B1 (bg) 1994-03-24
IL63980A (en) 1986-04-29
NO155885B (no) 1987-03-09
ES505950A0 (es) 1983-01-01
KR830007602A (ko) 1983-11-04
JPH021141B2 (en:Method) 1990-01-10
PL238035A1 (en) 1983-02-28
GB2084581B (en) 1985-02-27
GR75023B (en:Method) 1984-07-12
YU236481A (en) 1983-10-31
DK12391D0 (da) 1991-01-24
EP0049618B1 (en) 1985-08-14
ZA816817B (en) 1983-05-25
EP0049618A1 (en) 1982-04-14
NZ198523A (en) 1985-12-13
DK164056C (da) 1992-09-28
FI76570B (fi) 1988-07-29
FI76570C (fi) 1988-11-10
IE812285L (en) 1982-04-02
NO155885C (no) 1987-06-17
EG15678A (en) 1986-12-30
SU1184443A3 (ru) 1985-10-07
ES8301950A1 (es) 1983-01-01
AU542553B2 (en) 1985-02-28
PT73757B (en) 1983-01-13
DK435181A (da) 1982-05-12
AR241439A1 (es) 1992-07-31
IL63980A0 (en) 1982-01-31
MY8700247A (en) 1987-12-31
CA1166248A (en) 1984-04-24
DD200371A5 (de) 1983-04-20
PL233295A1 (en:Method) 1982-12-20
PL130526B1 (en) 1984-08-31
IE51603B1 (en) 1987-01-21

Similar Documents

Publication Publication Date Title
BG60249B2 (en) Thiazole compound for treatment of ulcers
IT8222608A0 (it) Procedimento per l'espossidazione di composti olefinici.
YU164791A (sh) Nezasićene hidroksialkilhinolin kiseline
IT1083151B (it) Procedimento d'idrocianazione di composti organici insaturi comportanti almeno un doppio etilenico
IT1113271B (it) Procedimento per l'isolamento di xilite
ES476343A1 (es) Procedimiento para la obtencion de ciclopentan-1-aminas
UA7228A1 (uk) Спосіб одержання похідних n-(4-індолілпіперідиноалкіл )бензімідазолону або їх солей з кислотами
MY102277A (en) Quinoline compounds
IT1126541B (it) Procedimento per l'assemblaggio di tubi
ATE46501T1 (de) Abkoemmlinge der guanidinomethylbenzoesaeure.
JO1704B1 (en) New potent compounds
IT1098840B (it) Procedimento per la produzione di 2-(3'-0 4'-amminofenil)-5 (06)-amminobenzimmidazoli
ES8602739A1 (es) Procedimiento para la fabricacion de nuevos derivados de la cumarina
FR2372165A1 (en:Method)
FR2360583A1 (fr) B-azolylcetones utiles comme fongicides
ES467069A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1-3-bencenodimetanol
OA07768A (fr) Dérivés d'anillines fongicides.
AP8800109A0 (en) "Heterocyclic insecticides".
IT8420682A1 (it) "Procedimento per il trattamento di articoli di maglieria"
ATE162717T1 (de) Behandlung kardialer dysfunktion mit 15- ketoprostaglandinderivaten
IT7819788A0 (it) Procedimento per fabbricazione dicomposti eterociclici e di biotina
FR2367761A1 (fr) Derives piperidylideniques de benzo-xanthenes,
FR2499815B1 (fr) Combinaison d'instruments pour travaux agricoles
BG31379A3 (bg) Метод за получаване на цефалоспорини
IT1199114B (it) Composto farmaceutico a base di dii droergotossina per il trattamento dell'ipertensione